James M Mock's Net Worth
$10.3 Million
Who is James M Mock?
James M Mock has an estimated net worth of $10.3 Million. This is based on reported shares across multiple companies, which include PERKINELMER INC, and Moderna, Inc..
SEC CIK
James M Mock's CIK is 0001736359
Past Insider Trading and Trends
2024 was James M Mock's most active year for acquiring shares with 15 total transactions. James M Mock's most active month to acquire stocks was the month of January. 2024 was James M Mock's most active year for disposing of shares, totalling 19 transactions. James M Mock's most active month to dispose stocks was the month of April. 2020 saw James M Mock paying a total of $84,446.12 for 20,561 shares, this is the most they've acquired in one year. In 2022 James M Mock cashed out on 11,471 shares for a total of $1,910,388.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PERKINELMER INC (RVTY) Snapshot price: $115.41
Please See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.41% | -5.03K |
$145.49 | -$731,092.42 | 27.58K |
Scheduled
|
Jun 24
| ||
Form 4
| +40.26% | 9.36K |
$182.95 | -$1,179,295.70 | 32.6K |
Feb 4 - Feb 7
| |||
Form 4
| -20.73% | -6.08K |
$184.87 | -$1,124,039.89 | 23.24K |
Scheduled
|
Sep 20
| ||
Form 4
| -12.02% | -4.00K |
$143.50 | -$574,717.50 | 29.32K |
May 17
| |||
Form 4
| -1.60% | -543.00 |
$130.99 | -$71,127.57 | 33.33K |
Apr 6
| |||
Form 4
| +8.58% | 2.68K |
—
|
—
| 33.87K |
Feb 5
| |||
Form 4
| +14.61% | 3.98K |
$147.07 | -$674,168.88 | 31.19K |
Feb 1
| |||
Form 4
| -17.12% | -5.62K |
$124.41 | -$699,584.34 | 27.22K |
Scheduled
|
Oct 2
| ||
Form 4
| -8.24% | -2.95K |
$91.97 | -$271,311.50 | 32.84K |
May 15
| |||
Form 4
| +3.24% | 1.12K |
$75.13 | $84,446.12 | 35.79K |
Apr 6
| |||
Form 4
| +11.70% | 3.62K |
—
|
—
| 34.57K |
Jan 30
| |||
Form 4
| -9.91% | -3.41K |
$89.04 | -$303,270.24 | 30.95K |
May 15
| |||
Form 4
| +10.50% | 3.26K |
—
|
—
| 34.35K |
Feb 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
∞
| 31.09K |
—
|
—
| 31.09K |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Moderna, Inc. (MRNA) Snapshot price: $72.23
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.94% | 167 |
$78.03 | -$12,640.21 | 8.77K |
Scheduled
|
Aug 28 - Aug 29
| ||
Form 4
| +18.31% | 1.33K |
$79.39 | -$104,880.66 | 8.6K |
Scheduled
|
Aug 27 - Aug 28
| ||
Form 4
| +11.73% | 763 |
$118.24 | -$81,465.36 | 7.27K |
Scheduled
|
Jul 5 - Jul 8
| ||
Form 4
| +10.82% | 635 |
$140.72 | -$97,237.38 | 6.51K |
Scheduled
|
May 31 - Jun 3
| ||
Form 4
| +2.53% | 145 |
$144.50 | -$26,444.36 | 5.87K |
Scheduled
|
May 28 - May 29
| ||
Form 4
| +13.43% | 678 |
$162.47 | -$105,282.89 | 5.73K |
Scheduled
|
May 24 - May 28
| ||
Form 4
| +17.40% | 748 |
$101.93 | -$71,859.31 | 5.05K |
Scheduled
|
Apr 5 - Apr 8
| ||
Form 4
| +18.39% | 668 |
$94.57 | -$61,188.08 | 4.3K |
Scheduled
|
Feb 28 - Feb 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +23.04% | 680 |
$109.75 | -$84,730.55 | 3.63K |
Scheduled
|
Jan 5 - Jan 8
| ||
Form 4
|
∞
| 2.95K |
$102.50 | -$292,952.72 | 2.95K |
Oct 5 - Oct 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||